THE BIO CONNECTION

Lilly announces proof of concept data for neutralizing antibody LY-CoV555 in the COVID-19 outpatient setting

By Staff Reports 7 months ago

Eli Lilly and Company said proof of concept data from an interim analysis of the

CU Researchers Come Together to Better Understand Ovarian Cancer Tumors and Treatment Outcomes

By Staff Reports 7 months ago

After nearly four years of work, a group of researchers and clinicians from the University

Antibody responses in COVID-19 patients could guide vaccine design

By Staff Reports 7 months ago

A comprehensive analysis of antibody responses in coronavirus disease 2019 (COVID-19) patients could inform the

Scientists Identify New Way To Target Some Rapidly Dividing Cancer Cells, Leaving Healthy Cells Unharmed

By Staff Reports 7 months ago

Scientists at Johns Hopkins Medicine and the University of Oxford say they have found a

Coronavirus COVID-19

Small Study Shows Convalescent Plasma is Safe to Use in Pediatric Patients with COVID-19

By Staff Reports 7 months ago

Early findings from researchers at Children’s Hospital of Philadelphia (CHOP)show that convalescent plasma appears to be

Coronavirus COVID-19

AstraZeneca COVID-19 vaccine study halted after ‘potentially unexplained’ illness

By Staff Reports 7 months ago

(AP) Late-stage studies of AstraZeneca’s COVID-19 vaccine candidate are on temporary hold while the company

cancer

Innovative, minimally invasive treatment can help maintain prostate cancer patients’ quality of life

By Staff Reports 7 months ago

For some prostate cancer patients, radical treatment (surgery or radiation) are treatment standards. However, these

Coronavirus COVID-19

Obese patients at high risk of severe COVID-19 illness, study finds

By Staff Reports 8 months ago

BLOOMBERG — Obese and overweight people are at high risk of suffering severe cases of

Preclinical study of COVID-19 vaccine candidate shows potent T-cell responses

By Staff Reports 8 months ago

Preclinical studies of a COVID-19 vaccine candidate at the University of Alabama at Birmingham show

New Treatment Developed by Children’s Hospital of Philadelphia Shows Success in High-Risk Solid Tumors

By Staff Reports 8 months ago

Despite intensive treatment, high-risk solid tumors like neuroblastoma, Ewing sarcoma, and rhabdomyosarcoma are challenging to

Targeted therapy combination effective for patients with advanced cholangiocarcinoma and BRAF mutations

By Staff Reports 8 months ago

In a Phase II trial led by researchers at The University of Texas MD Anderson

Uncategorized

Breakthrough led by NUS researchers provides new potential therapies for osteoporosis

By Staff Reports 8 months ago

A research team from the National University of Singapore (NUS) has identified a new avenue

UCI scientists get ‘initial hit’ in developing drug to treat COVID-19

By Staff Reports 8 months ago

When the coronavirus pandemic hit, almost everyone at the University of California, Irvine – and

CEL-SCI Announced Early Results with COVID 19 LEAPS Vaccine/Treatment

By Staff Reports 9 months ago

CEL-SCI Corporation announces that it has concluded animal experiments using its LEAPS COVID 19 conjugate

COVID-19: Patients Improve After Immune-Suppressant Treatment

By Staff Reports 9 months ago

Most patients hospitalized with COVID-19 (coronavirus) pneumonia experienced improvement after receiving a Food and Drug

Coronavirus COVID-19

Coronavirus COVID-19

How COVID-19 affects Pediatric Patients

By Staff Reports 10 months ago

New insights into the clinical and epidemiological characteristics of pediatric patients with coronavirus disease 2019